Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q5SI
|
|||
| Drug Name |
SHP611
|
|||
| Synonyms |
TAK611
Click to Show/Hide
|
|||
| Drug Type |
Recombinant protein
|
|||
| Indication | Metachromatic leukodystrophy [ICD-11: 5C56.02] | Phase 2 | [1] | |
| Company |
Takeda
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03771898) A Study of Intrathecal SHP611 in Participants With Late Infantile Metachromatic Leukodystrophy (Embolden). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.